"Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT01883297 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Recurrent
Platinum-resistant
High Grade Serous Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer

Interventions

BIOLOGICAL: Re-stimulated tumor-infiltrating lymphocytes (TILs)
BIOLOGICAL: Interleukin-2
DRUG: Cyclophosphamide

Sponsor

University Health Network, Toronto